IBDEI3A2 ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,55079,2)
 ;;=^5001764
 ;;^UTILITY(U,$J,358.3,55080,0)
 ;;=C92.02^^256^2775^6
 ;;^UTILITY(U,$J,358.3,55080,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,55080,1,3,0)
 ;;=3^Acute Myeloblastic Leukemia,In Relapse
 ;;^UTILITY(U,$J,358.3,55080,1,4,0)
 ;;=4^C92.02
 ;;^UTILITY(U,$J,358.3,55080,2)
 ;;=^5001791
 ;;^UTILITY(U,$J,358.3,55081,0)
 ;;=D09.3^^256^2775^43
 ;;^UTILITY(U,$J,358.3,55081,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,55081,1,3,0)
 ;;=3^Carcinoma in Situ of Thyroid/Oth Endocrine Glands
 ;;^UTILITY(U,$J,358.3,55081,1,4,0)
 ;;=4^D09.3
 ;;^UTILITY(U,$J,358.3,55081,2)
 ;;=^5001955
 ;;^UTILITY(U,$J,358.3,55082,0)
 ;;=C22.0^^256^2775^84
 ;;^UTILITY(U,$J,358.3,55082,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,55082,1,3,0)
 ;;=3^Hepatocellular Carcinoma
 ;;^UTILITY(U,$J,358.3,55082,1,4,0)
 ;;=4^C22.0
 ;;^UTILITY(U,$J,358.3,55082,2)
 ;;=^5000933
 ;;^UTILITY(U,$J,358.3,55083,0)
 ;;=C24.9^^256^2775^108
 ;;^UTILITY(U,$J,358.3,55083,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,55083,1,3,0)
 ;;=3^Malig Neop Biliary Tract,Unspec
 ;;^UTILITY(U,$J,358.3,55083,1,4,0)
 ;;=4^C24.9
 ;;^UTILITY(U,$J,358.3,55083,2)
 ;;=^5000942
 ;;^UTILITY(U,$J,358.3,55084,0)
 ;;=C50.922^^256^2775^132
 ;;^UTILITY(U,$J,358.3,55084,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,55084,1,3,0)
 ;;=3^Malig Neop Left Male Breast,Unspec Site
 ;;^UTILITY(U,$J,358.3,55084,1,4,0)
 ;;=4^C50.922
 ;;^UTILITY(U,$J,358.3,55084,2)
 ;;=^5133340
 ;;^UTILITY(U,$J,358.3,55085,0)
 ;;=C34.91^^256^2775^150
 ;;^UTILITY(U,$J,358.3,55085,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,55085,1,3,0)
 ;;=3^Malig Neop Right Bronchus/Lung,Unspec Part
 ;;^UTILITY(U,$J,358.3,55085,1,4,0)
 ;;=4^C34.91
 ;;^UTILITY(U,$J,358.3,55085,2)
 ;;=^5000967
 ;;^UTILITY(U,$J,358.3,55086,0)
 ;;=C50.921^^256^2775^154
 ;;^UTILITY(U,$J,358.3,55086,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,55086,1,3,0)
 ;;=3^Malig Neop Right Male Breast,Unspec Site
 ;;^UTILITY(U,$J,358.3,55086,1,4,0)
 ;;=4^C50.921
 ;;^UTILITY(U,$J,358.3,55086,2)
 ;;=^5001198
 ;;^UTILITY(U,$J,358.3,55087,0)
 ;;=C90.02^^256^2775^163
 ;;^UTILITY(U,$J,358.3,55087,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,55087,1,3,0)
 ;;=3^Multiple Myeloma,In Relapse
 ;;^UTILITY(U,$J,358.3,55087,1,4,0)
 ;;=4^C90.02
 ;;^UTILITY(U,$J,358.3,55087,2)
 ;;=^5001753
 ;;^UTILITY(U,$J,358.3,55088,0)
 ;;=Z85.818^^256^2776^92
 ;;^UTILITY(U,$J,358.3,55088,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,55088,1,3,0)
 ;;=3^Personal Hx of Malig Neop of Lip,Oral Cavity & Pharynx
 ;;^UTILITY(U,$J,358.3,55088,1,4,0)
 ;;=4^Z85.818
 ;;^UTILITY(U,$J,358.3,55088,2)
 ;;=^5063439
 ;;^UTILITY(U,$J,358.3,55089,0)
 ;;=Z85.819^^256^2776^93
 ;;^UTILITY(U,$J,358.3,55089,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,55089,1,3,0)
 ;;=3^Personal Hx of Malig Neop of Lip,Oral Cavity & Pharynx,Unspec
 ;;^UTILITY(U,$J,358.3,55089,1,4,0)
 ;;=4^Z85.819
 ;;^UTILITY(U,$J,358.3,55089,2)
 ;;=^5063440
 ;;^UTILITY(U,$J,358.3,55090,0)
 ;;=Z85.01^^256^2776^88
 ;;^UTILITY(U,$J,358.3,55090,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,55090,1,3,0)
 ;;=3^Personal Hx of Malig Neop of Esophagus
 ;;^UTILITY(U,$J,358.3,55090,1,4,0)
 ;;=4^Z85.01
 ;;^UTILITY(U,$J,358.3,55090,2)
 ;;=^5063395
 ;;^UTILITY(U,$J,358.3,55091,0)
 ;;=Z85.028^^256^2776^99
 ;;^UTILITY(U,$J,358.3,55091,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,55091,1,3,0)
 ;;=3^Personal Hx of Malig Neop of Stomach
 ;;^UTILITY(U,$J,358.3,55091,1,4,0)
 ;;=4^Z85.028
 ;;^UTILITY(U,$J,358.3,55091,2)
 ;;=^5063397
 ;;^UTILITY(U,$J,358.3,55092,0)
 ;;=Z85.038^^256^2776^90
 ;;^UTILITY(U,$J,358.3,55092,1,0)
 ;;=^358.31IA^4^2
